Co-Diagnostics, Inc.
CODX
$0.375
$0.01985.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 170.47% | 51.58% | -18.55% | -58.02% | -96.06% |
| Total Other Revenue | -100.00% | -81.29% | -- | -- | -- |
| Total Revenue | -95.80% | -73.91% | 1,243.17% | -22.28% | 153.67% |
| Cost of Revenue | -91.40% | 16.26% | -53.80% | -53.31% | 475.38% |
| Gross Profit | -118.00% | -84.39% | 1,035.59% | 134.00% | -33.69% |
| SG&A Expenses | 12.10% | 5.84% | -23.38% | -5.04% | -10.02% |
| Depreciation & Amortization | 14.13% | 18.53% | 10.85% | 4.62% | 4.79% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.61% | -4.54% | -15.22% | 1.65% | 26.75% |
| Operating Income | -0.69% | -14.54% | 35.97% | -3.10% | -10.18% |
| Income Before Tax | -1.82% | -19.50% | 32.07% | -15.90% | 56.71% |
| Income Tax Expenses | -100.21% | 101.05% | 100.92% | 101.01% | 222.14% |
| Earnings from Continuing Operations | 24.84% | -62.09% | 14.79% | -61.80% | 33.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.84% | -62.09% | 14.79% | -61.80% | 33.00% |
| EBIT | -0.69% | -14.54% | 35.97% | -3.10% | -10.18% |
| EBITDA | -0.33% | -14.40% | 37.19% | -3.05% | -10.33% |
| EPS Basic | 28.27% | -56.11% | 17.71% | -59.84% | 32.72% |
| Normalized Basic EPS | 0.79% | -10.74% | 39.99% | -3.98% | -9.13% |
| EPS Diluted | 28.08% | -57.09% | 18.61% | -56.00% | 32.61% |
| Normalized Diluted EPS | 0.79% | -10.74% | 39.99% | -3.98% | -9.13% |
| Average Basic Shares Outstanding | 4.78% | 3.86% | 3.56% | 1.22% | -0.41% |
| Average Diluted Shares Outstanding | 4.78% | 3.86% | 3.56% | 1.22% | -0.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |